Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Kyoko Fuse, MD, Takayuki Katagiri, MD, Yasuhiko Shibasaki, MD PhD, Tomoyuki Tanaka, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD, Tatsuo Furukawa, MD PhD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Takashi Ushiki, MD PhD

Blood (2016) 128 (22): 2297.

https://doi.org/10.1182/blood.V128.22.2297.2297

Published: 2016

Journal Articles

Log Reduction Levels of WT1 mRNA Expression in BM after Chemotherapies Are Predictive Markers of Good Prognosis in AML Patients Achieved CR after Induction Therapy

Yasuhiko Shibasaki, MD PhD, Yoshinobu Seki, MD PhD, Tomoyuki Tanaka, MD, Syukuko Miyakoshi, MD, Kyoko Fuse, MD, Takashi Kozakai, MD, Hironori Kobayashi, MD PhD, Takashi Ushiki, MD PhD, Takashi Abe, MD PhD, Toshio Yano, MD PhD, Masato Moriyama, MD PhD, Takashi Kuroha, MD PhD, Noriatsu Isahai, MD PhD, Jun Takizawa, MD, PhD, Miwako Narita, MD PhD, Satoru Koyama, MD PhD, Tatsuo Furukawa, MD PhD, Hirohito Sone, MDPhD, Masayoshi Masuko, MD PhD

Blood (2014) 124 (21): 2334.

https://doi.org/10.1182/blood.V124.21.2334.2334

Published: 2014

Journal Articles

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Masayoshi Masuko, MD, PhD, Tatsuo Furukawa, MD, PhD, Tadashi Koike, MD, Kazue Takai, MD, Koichi Nagai, MD, Kenji Kishi, MD, PhD, Yoshinobu Seki, MD, Hoyu Takahashi, MD, PhD, Sadao Aoki, MD, PhD, Takashi Kozakai, MD, Yasuhiko Shibasaki, MD, Takashi Ushiki, MD, Ken Toba, MD, PhD, Miwako Narita, MD, PhD, Masuhiro Takahashi, MD, PhD, Hirohito Sone, MD, PhD, Akira Shibata, MD

Blood (2013) 122 (21): 2744.

https://doi.org/10.1182/blood.V122.21.2744.2744

Published: 2013

Journal Articles

Clinical Factors Predicting the Response of Acute Graft-Versus-Host Disease to Corticosteroid Therapy.

Makoto Murata, MD, PhD, Hideki Nakasone, MD, Junya Kanda, MD, PhD, Takahiko Nakane, MD, PhD, Tatsuo Furukawa, MD, PhD, Takahiro Fukuda, MD, PhD, Shuichi Taniguchi, MD, PhD, Takehiko Mori, M.D., Tetsuya Eto, MD, PhD, Yasuo Morishima, M.D., Tokiko Nagamura-Inoue, MD, PhD., Hiromasa Yabe, Yoshiko Atsuta, MD, PhD, Hisashi Sakamaki, MD, Ritsuro Suzuki, M.D.

Blood (2012) 120 (21): 3046.

https://doi.org/10.1182/blood.V120.21.3046.3046

Published: 2012

Journal Articles

Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients

Masayoshi Masuko, MD, PhD, Tatsuo Furukawa, MD, PhD, Toyoyuki Tanaka, MD, Syukuko Miyakoshi, MD, Takashi Kozakai, MD, Kyoko Fuse, MD, Yasuhiko Shibasaki, MD, Kazue Takai, MD, Yoshinobu Seki, MD, Masashi Kobayashi, MD, Koichi Nagai, MD, Hoyu Takahashi, MD, Kenji Kishi, MD, PhD, Miwako Narita, MD, PhD, Masuhiro Takahashi, Tadashi Koike, MD, Akira Shibata, MD

Blood (2012) 120 (21): 3751.

https://doi.org/10.1182/blood.V120.21.3751.3751

Published: 2012

Journal Articles

Fludarabine-Based Reduced Intensity Hematopoietic Stem Cell Transplantation (RIST) for Patients Aged 50–70 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Heiwa Kanamori, MD, Shinichi Kako, MD, Harumi Kato, MD, Satoshi Nishiwaki, MD, Tatsuo Furukawa, MD, Mari Saito, MS, Shuichi Taniguchi, MD, PhD, Hirohisa Nakamae, MD, PhD, Toshiaki Yujiri, MD, Tokiko Naganuma-Inoue, MD, Yasuo Morishima, MD, PhD, Ritsuro Suzuki, MD, PhD, Hisashi Sakamaki, MD, Junji Tanaka, MD

Blood (2011) 118 (21): 1935.

https://doi.org/10.1182/blood.V118.21.1935.1935

Published: 2011

Journal Articles

Apoptosis of Leukemic Cells by Using tRNase Z L Under the Direction of Oncogene-Targeting Small Guide RNA.

Norihiro Watanabe, Miwako Narita, MD, Akie Yamahira, Tomoyo Taniguchi, Tatsuo Furukawa, MD, Tetsuo Yoshida, Tatsuya Miyazawa, Masayuki Nashimoto, Masuhiro Takahashi, MD

Blood (2010) 116 (21): 3763.

https://doi.org/10.1182/blood.V116.21.3763.3763

Published: 2010

Journal Articles

Tumor Antigen Small Guide (sg) RNA as a Completely Unique Nucleic Acid Medicine for Leukemia and Other Tumors.

Norihiro Watanabe, Miwako Narita, MD, Akie Yamahira, Nozomi Tochiki, Takeshi Nakamura, Anri Saitoh, Masami Kaji, Tomoyo Taniguchi, Tatsuo Furukawa, MD, Yoshifusa Aizawa, MD, Masayuki Nashimoto, Masuhiro Takahashi, MD

Blood (2009) 114 (22): 2461.

https://doi.org/10.1182/blood.V114.22.2461.2461

Published: 2009

Journal Articles

Effectiveness of WT1 Peptide Vaccination Combined with Imatinib in a Patient with CML in Chronic Phase.

Anri Saitoh, Miwako Narita, MD, Akie Yamahira, Takeshi Nakamura, Nozomi Tochiki, Norihiro Watanabe, Masami Kaji, Tomoyo Taniguchi, Masayoshi Masuko, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Ichiro Fuse, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2009) 114 (22): 4253.

https://doi.org/10.1182/blood.V114.22.4253.4253

Published: 2009

Journal Articles

A Unique Immunotherapeutic Atrategy by Using a Leukemic Plasmacytoid Dendritic Cell Line (PMDC05) as Potent Antigen Presenting Cells.

Takeshi Nakamura, Miwako Narita, MD, Akie Yamahira, Norihiro Watanabe, Nozomi Tochiki, Anri Saitoh, Masami Kaji, Tomoyo Taniguchi, Shigeo Hashimoto, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Ichiro Fuse, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2009) 114 (22): 5117.

https://doi.org/10.1182/blood.V114.22.5117.5117

Published: 2009

Journal Articles

Induction of Recipient Cell-Specific Donor T Cell Anergy by UV-C-Irradiated Recipient Immature Monocyte-Derived Dendritic Cells.

Nozomi Tochiki, Miwako Narita, MD, Zhiyin Zheng, MD, Chengfang Lu, MD, Norihiro Watanabe, Anri Saitoh, Noriyuki Satoh, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2007) 110 (11): 4897.

https://doi.org/10.1182/blood.V110.11.4897.4897

Published: 2007

Journal Articles

Anti-Tumor Cytotoxicity of γδ T Cells Expanded from Blood Cells of Myeloma and Leukemia Patients Against Self Tumor Cells — Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN, Dendritic Cells, and Activated αβ T Cells.

Anri Saito, Miwako Narita, MD, Norihiro Watanabe, Nozomi Tochiki, Noriyuki Satoh, Toshio Yano, MD, Jun Takizawa, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2007) 110 (11): 4762.

https://doi.org/10.1182/blood.V110.11.4762.4762

Published: 2007

Journal Articles

In Vitro Expansion of Blood γδ T Cells in Patients with Myeloma/Lymphoma and Anti-Tumor Cytotoxicity of the Expanded γδ T Cells.

Anri Saito, Miwako Narita, MD, Norihiro Watanabe, Nozomi Tochiki, Yumi Hiroi, Takayoshi Shirasaki, Jun Takizawa, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Sadao Aoki, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2006) 108 (11): 3895.

https://doi.org/10.1182/blood.V108.11.3895.3895

Published: 2006

Journal Articles

Human Plasmacytoid Dendritic Cell like Leukemia Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

Miwako Narita, MD, Nozomi Tochiki, Norihiro Watanabe, Anri Saitoh, Shigeo Hashimoto, MD, Junjiro Tsuchiyama, MD, Tatsuo Furukawa, MD, Sadao Aoki, MD, Ichiro Fuse, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2006) 108 (11): 4456.

https://doi.org/10.1182/blood.V108.11.4456.4456

Published: 2006

Journal Articles

Human Plasmacytoid Dendritic Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

Miwako Narita, MD, Nozomi Tochiki, Shigeo Hashimoto, MD, Asuka Sekiguchi, Norihiro Watanabe, Ayumi Yokoyama, Anri Saitoh, Junjiro Tsuchiyama, MD, Toshio Yano, MD, Masayoshi Masuko, MD, Ken Toba, MD, Tatsuo Furukawa, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2005) 106 (11): 4330.

https://doi.org/10.1182/blood.V106.11.4330.4330

Published: 2005

Journal Articles

Both Functions of Antigen Uptake/Presentation and Anti-Tumor Cytotoxicity Are Possessed by Human Blood γδ T Cells.

Norihiro Watanabe, Miwako Narita, MD, Ayumi Yokoyama, Asuka Sekiguchi, Anri Saito, Nozomi Tochiki, Jun Takizawa, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2005) 106 (11): 2383.

https://doi.org/10.1182/blood.V106.11.2383.2383

Published: 2005

Journal Articles

Anti-Tumor Cytotoxicity of Blood γδ T Cells Expanded from Leukemia Patients Against Autologous Leukemia Cells—Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN.

Anri Saito, Miwako Narita, MD, Norihiro Watanabe, Ayumi Yokoyama, Asuka Sekiguchi, Nozomi Tochiki, Louie Alldawi, MD, Jun Takizawa, MD, Shigeo Hashimoto, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD

Blood (2005) 106 (11): 2385.

https://doi.org/10.1182/blood.V106.11.2385.2385

Published: 2005

Journal Articles

Bestowing Transient Cytotoxic Capability on Dendritic Cells by Transfection with In Vitro Transcribed (IVT) TRAIL mRNA.

Norihiro Watanabe, Miwako Narita, MD, Toshio Yano, MD, Naoko Sato, MD, Asuka Sekiguchi, Anri Saito, Ayumi Yokoyama, Flavio Ayres, PhD, Louie Alldawi, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoko Watanabe, Yoshiaki Takahashi, PhD, Masuhiro Takahashi, MD

Blood (2004) 104 (11): 5282.

https://doi.org/10.1182/blood.V104.11.5282.5282

Published: 2004

Journal Articles

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

Nobuhiro Tsukada, MD, PhD, Tatsuo Furukawa, MD, PhD, Hiromi Ito, Noriko Izumi, MD, Akihito Momoi, MD, Kiyoshi Okazuka, MD, Keiichiro Honma, MD, Masayoshi Masuko, MD, PhD, Shigeo Hashimoto, MD, PhD, Sadao Aoki, MD, PhD, Yoshifusa Aizawa, MD, PhD

Blood (2004) 104 (11): 5076.

https://doi.org/10.1182/blood.V104.11.5076.5076

Published: 2004

Journal Articles

Enhancing Effects of Heparin/Low Molecular Weight Heparin/Heparan Sulfate on Antigen Presentation and Antigen-Specific Cytotoxic T Lymphocyte (CTL) Induction by Monocyte-Derived Dendritic Cells.

Asuka Sekiguchi, Miwako Narita, MD, Toshio Yano, MD, Naoko Sato, MD, Anri Saito, Norihiro Watanabe, Ayumi Yokoyama, Flavio Ayres, PhD, Louie Alldawi, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoko Watanabe, Yoshiaki Takahashi, PhD, Masuhiro Takahashi, MD

Blood (2004) 104 (11): 3816.

https://doi.org/10.1182/blood.V104.11.3816.3816

Published: 2004

NARROW

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Log Reduction Levels of WT1 mRNA Expression in BM after Chemotherapies Are Predictive Markers of Good Prognosis in AML Patients Achieved CR after Induction Therapy

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Clinical Factors Predicting the Response of Acute Graft-Versus-Host Disease to Corticosteroid Therapy.

Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients

Fludarabine-Based Reduced Intensity Hematopoietic Stem Cell Transplantation (RIST) for Patients Aged 50–70 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Apoptosis of Leukemic Cells by Using tRNase Z L Under the Direction of Oncogene-Targeting Small Guide RNA.

Tumor Antigen Small Guide (sg) RNA as a Completely Unique Nucleic Acid Medicine for Leukemia and Other Tumors.

Effectiveness of WT1 Peptide Vaccination Combined with Imatinib in a Patient with CML in Chronic Phase.

A Unique Immunotherapeutic Atrategy by Using a Leukemic Plasmacytoid Dendritic Cell Line (PMDC05) as Potent Antigen Presenting Cells.

Induction of Recipient Cell-Specific Donor T Cell Anergy by UV-C-Irradiated Recipient Immature Monocyte-Derived Dendritic Cells.

Anti-Tumor Cytotoxicity of γδ T Cells Expanded from Blood Cells of Myeloma and Leukemia Patients Against Self Tumor Cells — Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN, Dendritic Cells, and Activated αβ T Cells.

In Vitro Expansion of Blood γδ T Cells in Patients with Myeloma/Lymphoma and Anti-Tumor Cytotoxicity of the Expanded γδ T Cells.

Human Plasmacytoid Dendritic Cell like Leukemia Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

Human Plasmacytoid Dendritic Cell Line (PMDC05) Established from a Patient with CD4 + CD56 + Acute Leukemia.

Both Functions of Antigen Uptake/Presentation and Anti-Tumor Cytotoxicity Are Possessed by Human Blood γδ T Cells.

Anti-Tumor Cytotoxicity of Blood γδ T Cells Expanded from Leukemia Patients Against Autologous Leukemia Cells—Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN.

Bestowing Transient Cytotoxic Capability on Dendritic Cells by Transfection with In Vitro Transcribed (IVT) TRAIL mRNA.

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

Enhancing Effects of Heparin/Low Molecular Weight Heparin/Heparan Sulfate on Antigen Presentation and Antigen-Specific Cytotoxic T Lymphocyte (CTL) Induction by Monocyte-Derived Dendritic Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only